Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
As of Nov 13, 2026, ANDA 75845 (Oxaprozin), held by Pangea, was first approved by FDA on Jan 31, 2001, with 10 approved supplements and 0 published complete response letters.
First approved: Jan 31, 2001
Supplements approved: 10
Complete response letters: 0
Approvals and New Uses
The original application and every efficacy supplement, newest first; all 11 submissions below
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters.Drugs@FDA and FDA complete response letters
